Aura 2016 Supplementary data

Table S4.35 Methicillin-resistant Staphylococcus aureus resistance, by healthcare-associated and community-associated clones (blood culture isolates), 2014

Antimicrobial	Healthcare associated, % resistant (n)	Community associated, % resistant (n)	Total, % resistant (n)
Penicillin	100.0 (163)	100.0 (239)	100.0 (402)
Oxacillin	99.4 (163)	95.4 (240)	97.0 (403)
Ciprofloxacin	98.2 (163)	19.6 (240)	51.4 (403)
Erythromycin	71.2 (163)	33.3 (240)	48.6 (403)
Clindamycin	29.4 (163)	7.1 (240)	16.1 (403)
Trimethoprim–sulfamethoxazole	22.1 (163)	5.9 (239)	12.4 (402)
Gentamicin	28.8 (163)	9.6 (240)	17.4 (403)
Rifampicin	1.2 (162)	0.8 (239)	1.0 (401)
Fusidic acid	2.5 (163)	5.4 (240)	4.2 (403)
Linezolid	0.0 (163)	0.8 (240)	0.5 (403)
Daptomycin	3.1 (161)	0.4 (240)	1.5 (401)
Tetracycline	29.4 (163)	11.3 (240)	18.6 (403)
Nitrofurantoin	0.0 (161)	0.0 (235)	0.0 (396)
Vancomycin	0.0 (163)	0.0 (240)	0.0 (403)

Source: AGAR

Table S4.36 Methicillin-resistant Staphylococcus aureus healthcare-associated and community-associated clones, by jurisdiction (blood culture isolates), 2014

Jurisdiction	Total isolates	% MRSA	No. typed	Community associated, % of total (n)	Healthcare associated, % of total (n)
ACT	79	12.7	10	1.3 (1)	11.4 (9)
NSW	516	24.8	125	11.0 (57)	13.2 (68)
NT	64	42.2	27	34.4 (22)	7.8 (5)
Qld	550	17.8	96	12.0 (66)	5.5 (30)
SA	196	20.9	37	11.2 (22)	7.7 (15)
Tas	52	3.8	2	1.9 (1)	1.9 (1)
Vic	426	15.3	61	8.0 (34)	6.3 (27)
WA	323	13.9	45	11.5 (37)	2.5 (8)
Australia	2206	18.9	403	10.9 (240)	7.4 (163)

ACT = Australian Capital Territory; MRSA = methicillin-resistant Staphylococcus aureus; NSW = New South Wales; NT = Northern Territory; Qld = Queensland; SA = South Australia; Tas = Tasmania; Vic = Victoria; WA = Western Australia

Note: 97% of MRSA were available for typing to determine sequence type. Based on sequence type, MRSA were classified as either healthcare-associated or community-associated clones.

Source: AGAR (national)

Table S4.37 Streptococcus agalactiae resistance (all specimen sources), 2014

Antimicrobial	% resistant	No. of isolates tested
Penicillin	0.0	769
Ampicillin	0.0	1221
Erythromycin	22.7	772
Clindamycin	17.1	672
Norfloxacin	39.9	1216
Trimethoprim	17.2	1221

Sources: OrgTRx (Queensland); SNP (Queensland and northern New South Wales)

Table S4.38 Streptococcus agalactiae resistance, by clinical setting, 2014

Antimicrobial	Public hospitals and health services, % resistant (n)	Community, % resistant (n)	Residential aged care facilities, % resistant (n)
Penicillin	0.0 (769)	na	na
Ampicillin	na	0.0 (1126)	0.0 (95)
Erythromycin	22.7 (772)	na	na
Clindamycin	17.1 (672)	na	na
Trimethoprim	na	17.7 (1126)	11.6 (95)
Norfloxacin	na	40.1 (1121)	36.8 (95)

na = not available (either not tested or tested against an inadequate number of isolates)

Sources: OrgTRx, Queensland (public hospitals and health services); SNP (community and residential aged care facilities)

Table S4.39 Streptococcus pneumoniae resistance, by specimen source, 2014

Antimicrobial	Blood, % resistant (n)	Cerebrospinal fluid, % resistant (n)	Other, % resistant (n)	All sources, % resistant (n)
Penicillin	2.3 (175)	14.3 (7)	2.0 (2257)	2.1 (2439)
Erythromycin	21.1 (19)	na	25.9 (2283)	25.8 (2302)
Tetracycline	21.1 (19)	na	25.6 (121)	25.0 (140)
Trimethoprim–sulfamethoxazole	21.1 (19)	na	29.9 (1117)	29.8 (1136)

na = not available (either not tested or tested against an inadequate number of isolates)

Sources: OrgTRx (Queensland); SNP (Queensland and northern New South Wales)

Table S4.40 Streptococcus pneumoniae resistance, by clinical setting, 2014

Antimicrobial	Public hospitals and health services, % resistant (n)	Private hospitals, % resistant (n)	Community, % resistant (n)	Residential aged care facilities, % resistant (n)
Penicillin	2.6 (1312)	3.1 (131)	1.3 (989)	0.0 (7)
Erythromycin	22.1 (1170)	30.0 (130)	29.6 (995)	42.9 (7)
Tetracycline	na	26.6 (128)	0.0 (5)	14.3 (7)
Trimethoprim–sulfamethoxazole	na	27.5 (131)	30.0 (997)	37.5 (8)

na = not available (either not tested or tested against an inadequate number of isolates)

Sources: OrgTRx, Queensland (public hospitals and health services); SNP (private hospitals, community and residential aged care facilities)

Table S4.41 Streptococcus pyogenes resistance (all specimen sources), 2014

Antimicrobial	% resistant	No. of isolates tested
Penicillin	0.0	9934
Erythromycin	3.4	9880
Tetracycline	13.9	122
Trimethoprim–sulfamethoxazole	1.2	4782

Sources: OrgTRx (Queensland); SNP (Queensland and northern New South Wales)

Table S4.42 Streptococcus pyogenes resistance, by clinical setting, 2014

Antimicrobial	Public hospitals and health services, % resistant (n)	Private hospitals, % resistant (n)	Community, % resistant (n)	Residential aged care facilities, % resistant (n)
Penicillin	0.0 (5155)	0.0 (100)	0.0 (4 186)	0.0 (28)
Erythromycin	2.3 (5095)	7.0 (100)	4.4 (4657)	7.1 (28)
Tetracycline	na	14.9 (94)	na	10.7 (28)
Trimethoprim–sulfamethoxazole	na	4.1 (98)	1.1 (4656)	0.0 (28)

na = not available (either not tested or tested against an inadequate number of isolates)

Sources: OrgTRx, Queensland (public hospitals and health services); SNP (private hospitals, community and residential aged care facilities)